<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="31109" whole_study_id="31109" phs="001685" v="1" p="1" createDate="2018-08-31T13:09:13-05:00" completedByGPADate="2018-08-31T13:17:56-05:00" modDate="2022-01-25T16:16:17-05:00" maxParentChildStudyModDate="2022-01-25T16:16:17-05:00" handle="OvarianCancerOrganoids" num_participants="23"><StudyInfo accession="phs001685.v1.p1" parentAccession="phs001685.v1.p1"><BioProject id="PRJNA489928" entrez_id="489928" type="bp_admin_access"/><BioProject id="PRJNA489929" entrez_id="489929" type="bp_data_submission"/><StudyNameEntrez>Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>R37 HL052725, P01 HL048546, UM1 CA186709</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="false"/></ICs><Persons><Person aid="8" auth="virtual" fname="Alan" lname="D'Andrea" email="Alan_Dandrea@dfci.harvard.edu"><Role>PI</Role><Organization/></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Sarah" lname="Hill" email="sarah_hill@dfci.harvard.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>We would like to thank the patients and clinicians who supported this work. The work was supported by grants from the U.S. Department of Defense (BC151331P1), the U.S. National Institutes of Health (R37 HL052725, P01 HL048546), the Leukemia and Lymphoma Society (6237-13), the Breast Cancer Research Foundation, the Richard and Susan Smith Family Foundation, and the Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center (to ADD). The work was also supported by a Stand Up To Cancer-Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant (Grant Number: SU2C-AACR-DT16-15). Stand Up To Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. The work was also supported by UM1 CA186709 (to GIS and ADD). Please acknowledge and reference the Cancer Discovery publication (PMID: 30213835).</acknowledgement_statement><ic_specific_access_term>This study has two consent groups: (1) HMB - Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry; and (2) DS-GC - Use of the data must be related to Gynecological Cancer.</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="3205" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup><ConsentGroup uid="3215" CGType="cg_class_DS" title="Disease-Specific (Gynecological Cancer)" name="DS-GC" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Gynecological Cancer.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>